• Home
  • About Us
  • Advisory board
  • Topics
    • Arrhythmia
    • Atrial Fibrillation
    • Atherosclerosis
    • Cardiovascular Disease
    • Congenital Conditions
    • Diabetes
    • Devices
    • Electro-physiology
    • Heart Failure
    • Hypertension
    • Imaging
    • Interventional Cardiology
    • Stroke
    • Thrombosis
    • All Videos
  • CME
  • Podcasts
  • Contact Us
CARDIOLINE SpA – Interview with President: Fabio Rangoni at ESC 2019, Paris, France

CARDIOLINE SpA – Interview with President: Fabio Rangoni at ESC 2019, Paris, France

by Ket Patel | Dec 4, 2019 | Devices

Fabio Rangoni – President – CARDIOLINE SpA Video interview was conducted by Oruen-Cardiology at ESC 2019 in Paris, France. For further information on CARDIOLINE, please visit www.cardioline.it
Acarix – CAD device – Dr Werner Kommer and Jörg Domes Interviews at ESC 2019, Paris, France

Acarix – CAD device – Dr Werner Kommer and Jörg Domes Interviews at ESC 2019, Paris, France

by Ket Patel | Dec 4, 2019 | Devices

The following interviews were taken at ESC 2019, Paris, France Dr Werner Kommer Specialist in Internal Medicine and a Cardiology General Practitioner   Jörg Domes Sales Director – Acarix   For further information on Acarix, please visit...

What do we know about dabigatran in elderly patients?

by Ket Patel | Oct 1, 2019 | Arrhythmia, Atrial Fibrillation, Home video

Based on the patient characteristics of an elderly AF patient with renal impairment Dr. John W. Eikelboom will review existing data from multiple sources including RE-LY subgroup data to support the dabigatran treatment decision for this...

What do we know about dabigatran in patients with cardiovascular disease?

by Ket Patel | Oct 1, 2019 | Arrhythmia, Atrial Fibrillation, Cardiovascular Disease, Home video

Based on the patient characteristics of an AF patient with cardiovascular comorbidities Dr. John W. Eikelboom will review existing data from multiple sources including RE-LY subgroup data, GLORIA AF and RE-DUAL PCI to support the dabigatran treatment decision for this...
Dabigatran, a direct thrombin inhibitor, reduces the risk of an intracerebral haemorrhage: Protection of the blood brain barrier

Dabigatran, a direct thrombin inhibitor, reduces the risk of an intracerebral haemorrhage: Protection of the blood brain barrier

by Ket Patel | Oct 1, 2019 | Arrhythmia, Atrial Fibrillation, Cardiovascular Disease, Home video

This is a video showing the MOA of thrombin inhibition on  intracranial haemorrhage. It shows how dabigatran, a thrombin inhibitor minimises thrombin mediated damage and preserves the brain barrier, thereby minimising intracranial hemorage. It showcases the RE-LY...
Page 17 of 25« First«...10...1516171819...»Last »

Connect With Us

[v_social_accounts]

[show_right_sidebar_slider]
Want to be the first to know when new content is available? Subscribe for free to our newsletter.

Subscribe

Oruen-Cardiology is the leading multimedia platform – committed to improving international communication and medical education for physicians with clinical interests in Cardiology.
Navigation
  • Home
  • About Us
  • Advisory Board
  • Contact Us
  • Subscribe
  • Terms and conditions
  • Site Map
  • Privacy Policy
Contact Oruen

Name: Dr. James Coe  (MD, PhD)

Editor

E-mail: editor@oruen-cardiology.com

  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2024. Oruen LTD. All Rights Reserved. | Terms & Conditions | Privacy Policy | Sitemap